MedTrace Logo

Molecular Characterization of Primary Mucosal Melanoma

NCT03319693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2024-08-22

No results posted yet for this study

Summary

Primary mucosal melanomas (MPM) are rarer than cutaneous melanomas, but also more severe. They are usually refractory to conventional approaches, regularly excluded from major therapeutic programs and not sensitive to new targeted therapies orphans. " The identification of therapeutic targets and accessibility to existing, developing or future targeted therapies improves the survival of patients with MPM.

The principal goal is to describe, using a large panel of genes, the prevalence of major mutations in a cohort of MPMs based on the population of a French region.

Conditions

  • Mucosal Melanoma

Interventions

GENETIC

Somatic Genetic

NGS analysis

Sponsors & Collaborators

  • CHU de Reims

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-28
Primary Completion
2019-04-28
Completion
2021-04-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03319693 on ClinicalTrials.gov